Metastatic Hormone Refractory Prostate Cancer Withdrawn Phase 4 Trials for Bicalutamide (DB01128)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00255268CMAB vs IMAB in Metastatic Prostate CancerTreatment